Funding of innovations in medical research regarding covid-19
Through the EU initiative IMI, researchers can now apply for research funding of medical innovations to stop the spread of the novel coronavirus.
Innovative Medicines Initiative, IMI, is a joint initiative of the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA). With deadline March 31, innovation projects are funded from research around the covid-19 outbreak, the so-called coronavirus.
The projects can be about antiviral agents, diagnostics or tools to deal with current and future outbreaks of covid-19. The total budget for the call for proposal is 45 million EUR.
Objectives
Considering that this is a newly-identified virus, the scope of this topic remains broad and must address at least one of the following objectives:
- Development of antivirals as well as other types of therapeutics to address a rapid response to the current COVID-19 outbreak.
- Development of therapeutics to address the current and/or future coronavirus outbreaks.
- Development of diagnostics, ensuring rapid evaluation of candidates based on existing technologies.
- Development of fast and reliable tools that go beyond the state of the art for detection of COVID-19 carriers and symptomatic individuals suspected of COVID-19 infection.
Apply
Learn more and apply at IMI2 - Call 21 (imi.europa.eu).